Cargando…
A double‐blind randomised feasibility trial of angiotensin‐2 in cardiac surgery(*)
Acute kidney injury is common after cardiac surgery. Vasoplegic hypotension may contribute to kidney injury, and different vasopressors may have variable effects on kidney function. We conducted a double‐blind, randomised feasibility trial comparing peri‐operative angiotensin‐2 with noradrenaline. W...
Autores principales: | Coulson, T. G., Miles, L. F., Serpa Neto, A., Pilcher, D., Weinberg, L., Landoni, G., Zarbock, A., Bellomo, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543254/ https://www.ncbi.nlm.nih.gov/pubmed/35915923 http://dx.doi.org/10.1111/anae.15802 |
Ejemplares similares
-
Angiotensin II infusion in COVID-19-associated vasodilatory shock: a case series
por: Zangrillo, Alberto, et al.
Publicado: (2020) -
Angiotensin II - A Brief Review and Role in Severe SARS-COV-2 Sepsis
por: Carà, Gianmarco A., et al.
Publicado: (2022) -
Feasibility and safety of angiotensin II administration in general ward patients during COVID-19 pandemic: a case series
por: Morselli, Federica, et al.
Publicado: (2023) -
Why the renin–angiotensin–aldosterone system (RAAS) in critically ill patients can no longer be ignored
por: Zarbock, Alexander, et al.
Publicado: (2021) -
Angiotensin II infusion in COVID‐19: An international, multicenter, registry‐based study
por: Serpa Neto, Ary, et al.
Publicado: (2022)